RCC1 and colorectal carcinoma: Taken together, these findings suggest that RCC1 knockdown sensitizes both parental and drug-resistant CRC cells to 5-FU and Doxo by activating the ATM/ATR-CHK1/CHK2-p53-p21 signaling axis, thereby promoting cell cycle arrest and apoptosis.